Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Canvert
- Development stage
- Preclinical
- Lead developer
- Alasht Pharmed
- Administration
- Topical
01
Overview
Canvert is a cosmeceutical cream developed by Alasht Pharmed specifically for the relief of chronic pain. As a cosmeceutical, the product is positioned between a cosmetic and a pharmaceutical, intended to provide therapeutic benefits through topical application. It is part of a specialized product range that includes Canvert Pro for acute pain, Canvert Silk for acne, and Canvert M for headaches. The formulation is designed for localized treatment, though the specific active ingredients and their exact mechanisms of action have not been publicly detailed in the company's pipeline documentation.
- Brand names
- Canvert
Beyond the preview
Go deeper on Canvert.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Canvert.